Gene · 23600
AMACR: alpha-methylacyl-CoA racemase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AMACR: alpha-methylacyl-CoA racemase. Genes, record 23600. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23600
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UHK6 | Alpha-methylacyl-CoA racemase | 382 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 356 | Q9UHK6 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37163 | Q9UHK6 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 6100 | Q9UHK6 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6100 | Q9UHK6 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4320 | Q9UHK6 | Espacenet |
| JP 2023521663 A | 2023-05-25 | 355 | Q9UHK6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 4320 | Q9UHK6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 107291 | Q9UHK6 | Espacenet |
| JP 2021530985 A | 2021-11-18 | 463 | Q9UHK6 | Espacenet |
| WO 2021202604 A1 | 2021-10-07 | 356 | Q9UHK6 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants677
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AMACR papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 17 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 12 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 8 | 2025 |
| U01CA113913 | Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P50CA092629 | SPORE in Prostate Cancer | 7 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 6 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 5 | 2025 |
| P50CA186786 | Michigan Prostate SPORE 2025-2030 | 5 | 2025 |
| R01CA241164 | Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma | 4 | 2025 |
1 to 10 of 677Source NIH's project files
See all 677 nih grantsPapers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Refining prostate cancer diagnosis: correlative analysis of Gleason scores and immunohistochemical markers. | Diagn Pathol | 2026 | 42823706 | PubTator, text mining | PubMed |
| Expanding the clinicopathological spectrum of BAP1 mutated ccRCC: a study of 84 cases in multi-center cohort. | Hum Pathol | 2026 | 42822734 | PubTator, text mining | PubMed |
| Solitary Testicular Metastasis as the Only Site of Recurrence in Prostate Adenocarcinoma. | Cureus | 2026 | 42799107 | PubTator, text mining | PubMed |
| Triple detection of the tumor proteins p63, Ki-67 and Alpha-methylacyl-CoA racemase in the pathological diagnosis of prostate cancer. | J Med Biochem | 2026 | 42781326 | PubTator, text mining | PubMed |
| Histopathological Study of Prostate Core Needle Biopsies in Enugu, Southeast Nigeria and the Role of Immunohistochemistry in Resolving Diagnostic Dilemmas. | Niger Med J | 2026 | 42676831 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma With Hemangioblastoma-Like Features, Fibromyomatous Stroma, and TSC1 Mutation. | Case Rep Med | 2026 | 42638884 | PubTator, text mining | PubMed |
| Kinase Fusions Define a Distinct Subset of BRAF V600E‑Negative Metanephric Adenomas : A Multi-Institutional Study of 7 Cases. | Am J Surg Pathol | 2026 | 42638313 | PubTator, text mining | PubMed |
| Upper tract urothelial carcinoma mimicking emphysematous pyelonephritis: a diagnostic challenge case report. | Int J Surg Case Rep | 2026 | 42578240 | PubTator, text mining | PubMed |
| Clear Cell Carcinoma of the Left Colon: A Case Report. | Am J Case Rep | 2026 | 42563356 | PubTator, text mining | PubMed |
| Papillary Hyperplasia in Autosomal Dominant Polycystic Kidney Disease: A Multi-Institutional Study With Immunohistochemical and Molecular Characterization. | Am J Surg Pathol | 2026 | 42548188 | PubTator, text mining | PubMed |
1 to 10 of 2,301
See all 2,301 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23600
GET https://conductscience.org/api/genes/v1/23600/patents?page=2